Bio Medica Laboratories Limited (NSE:BMLL)

Market Cap	1.83B
Revenue (ttm)	430.90M +103.0%
Net Income	117.81M +1,900.1%
EPS	12.83 +1,900.1%
Shares Out	12.58M
PE Ratio	11.33
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	26,000
Open	145.35
Previous Close	151.95
Day's Range	145.35 - 145.35
52-Week Range	101.50 - 181.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 27, 2026

About Bio Medica Laboratories

Bio Medica Laboratories Limited engages in manufacturing, marketing, trading, import and export of pharmaceutical products in India. The company offers medicines; bulk drugs; and chemicals and allied healthcare products, including antibiotic, ayurvedic, allopathic, and homeopathic products, as well as operates hospitals, clinics, diagnostic centers, laboratories, and other healthcare facilities, including medical research and related healthcare services. It also provides human and veterinary injectables products. The company was formerly known ...

• Industry: Pharmaceutical Preparations
• Founded: 1988
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BMLL

Financial Performance

In fiscal year 2026, Bio Medica Laboratories's revenue was 430.90 million, an increase of 12.45% compared to the previous year's 383.20 million. Earnings were 117.81 million, an increase of 21.40%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 6, 2026

Data Sources Report a data error